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THE UNIFIED PATENT COURT AND PATENT
TROLLS IN EUROPE
Jonathan I. Tietz*
Healthy organisms inevitably produce cancer cells, and vibrant
patent systems inevitably let bad patents slip through. These patents
are harnessed by entities that leverage the uncertainty and expense of
litigation to extract licenses from technological practitioners. Postissuance patent review (PIPR) has emerged as an invaluable errorcorrecting mechanism to prevent the socially harmful assertion of
improperly issued patents. The United States, with the America Invents
Act, established a new system for PIPR, expanding administrative
routes to curtail bad patents. Europe is going a step further with the
Unified Patent Court Agreement (UPCA). The UPCA enables a lowcost patent revocation action on a broad range of grounds and with a
relaxed standing requirement. But this is an opt-in system with a loserpays fee-shifting arrangement. Thus, although the structure of the
Unified Patent Court (UPC) appears to be set up to facilitate efficient
PIPR, the disincentives for opting in suggest that the UPC will be a
less effective troll-fighting vehicle than expected. Indeed, patent trolls
may simply opt for national patent systems.
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Introduction
In 2013, twenty-five European Union member states signed the Agreement on a Unified Patent Court (UPCA), which establishes a new category
of international patent under the exclusive jurisdiction of a centralized Unified Patent Court (UPC). The UPCA is meant to unify patent rights, decrease litigation and administration costs, and provide a means for improved
post-issuance correction of erroneous patents. In part, this is intended to curtail the practices of so-called patent trolls, nonpracticing patent-owning entities that assert bad patents against practicing third parties.
Structurally, the system is remarkably broad compared to those already
in Europe and the United States. Compared to post-issuance patent review
(PIPR) in the United States, the UPC could function as a more effective error-correction mechanism. Under the UPCA, revocation actions will be
available for essentially any substantive ground of unpatentability, with
amendment of the patent in question available as an alternative to wholesale
revocation. On the other hand, several structural features suggest that UPCA
may not effectively prevent patent-troll behavior. Namely, the combination
of an apparently lax standing requirement, a loser-pays fee-shifting structure, a lack of judicial review, and a lack of preemption of national patent
laws may dissuade unitary patent filings. This is especially likely because
the patents most valuable to patent trolls are, due to geographical industrial
asymmetry, only valuable in certain states. That is, the opt-in cost may outweigh the benefits.
This Note contends that the seemingly effective error-correction mechanisms created by the UPC may actually go too far, being too costly for patent owners to opt into the system. Part I outlines the importance of PIPR,
particularly in the context of patent trolls. Part II reviews the structures of
existing PIPR systems in the United States and Europe. Part III characterizes the structure of PIPR under the UPC. Part IV views this structure through
the lens of patent trolls, compares it with the United States, and asserts that
certain aggressive features may nudge patent trolls to opt for national patent
systems instead.
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I. The Importance of Post-Issuance Patent Review
1

Many consider strong patent protection to be essential for innovation.
But overprotection of intellectual property can impede scientific and eco2
nomic progress. Accordingly, the structure of any given patent examination
system reflects pragmatic compromises. The result is that even in a vibrant,
innovation-rich patent system, two troublesome problems emerge.
First, bad, overbroad patents inevitably slip through. Second, there are
perverse economic incentives to take advantage of these bad patents in the
context of other structural elements of a patent protection system. The re3
sult? So-called patent trolls.

A. The Bad Patent Problem
4

Every patent system includes substantive patentability requirements.
5
The novelty and inventive-step (or non-obviousness) requirements are the
most fundamental. These “doctrinal screens” are meant to ensure that the
exclusivity of a patent is only available to truly new inventions. Any ineffectiveness of administering certain doctrinal screens might inadvertently
1.
See, e.g., Dan L. Burk & Mark A. Lemley, Policy Levers in Patent Law, 89 VA. L.
REV. 1575, 1576 (2003) (“Patent law is our primary policy tool to promote innovation, encourage the development of new technologies, and increase the fund of human knowledge.”).
But see Rachel E. Sachs, The Uneasy Case for Patent Law, 117 MICH. L. REV. 499 (2018).
2.
See, e.g., Rebecca S. Eisenberg, Technology Transfer and the Genome Project:
Problems with Patenting Research Tools, 5 RISK: HEALTH, SAFETY & ENV’T 163, 175 (1994)
(“Overprotecting intellectual property is as harmful as underprotecting it.” (quoting Vanna
White v. Samsung Elecs. Am., Inc., 989 F.2d 1512, 1513 (9th Cir. 1993))); see also Michael
A. Heller & Rebecca S. Eisenberg, Can Patents Deter Innovation? The Anticommons in Biomedical Research, 280 SCIENCE 698 (1998) (noting problems of patent overprotection even in
technologies where patents are typically considered essential).
3.
The patent troll problem is not strictly limited to bad patents. In a practice referred
to as “holdup,” a nonpracticing owner of an otherwise valid patent waits to enforce patent
rights until it is strategic to do so—for instance, not when first learning that another company
has infringed but perhaps when the company has been particularly successful. In the absence
of laches defenses, this practice seems troublesome: after all, the nonpracticing patent owners
are not themselves practicing, or even licensing, the patented technology and is thus not economically harmed by infringement; in contrast, the infringer is arguably increasing the public
good and is harmed by relying on the patent owner’s non-assertion (especially when the vast
universe of patents in densely crowded fields makes accidental infringement likely). But
where the patent is technically valid and in compliance with the underlying standards of patentability, it is not normatively obvious that this is the same problem, especially in the absence in law of a patent use requirement. In contrast, the assertion of improperly issued, technically flawed patents plainly frustrates the purpose of the patent system and is difficult to
defend. Accordingly, a thorough discussion of structural (dis)incentives of holdup-style patent
trolling in the context of the European Union is beyond the scope of this manuscript.
4.
These are also called “doctrinal screens.” Christopher Buccafusco et al., Intelligent
Design, 68 DUKE L.J. 75 (2018) (discussing the role of doctrinal screens in calibrating intellectual property rights).
5.
In contrast to much of the world, the United States’s term for “inventive step” is
“non-obviousness.” See 35 U.S.C. § 103 (2012).
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allow overbroad patents to issue. But one of the fundamental causes of bad
patents is simply inherent in the nature of progress. The universe of known
6
technologies grows each day; the time spent on patent examination does
7
not. Thus, patents that impermissibly overlap with known technology are
8
frequently issued in error.

B. Paying the Troll Toll: Impact and Drivers of Troll Activity
Structural features of patent law incentivize taking advantage of bad pa9
tents through a practice known as patent trolling. Patent trolls are nonprac10
ticing owners of patents who seek out potential infringers, wait for the infringers to find financial success, and then threaten to sue, hoping to obtain
favorable settlements. Trolls often rely on vaguely worded patents with un11
certain scopes.
Patent litigation is expensive, complex, and uncertain—in the face of
complicated technologies and at-times-fuzzy patent doctrines, determining
infringement is difficult, especially for generalist judges and lay juries. So
even if an asserted patent is probably bad, a defendant is likely to settle
simply to mitigate the nuisance, risk, and expense of the lawsuit.
How substantial is the problem? Patent troll behavior hampers innovation and generates waste, both in terms of litigation resources and lost
12
wealth—to the tune of hundreds of billions of dollars. There is generally
6.
It is hard to overstate the volume of previous technology. Relevant prior art includes all previous patents, written publications, products, and public presentations, among
other forms prior art. More than ten million utility patents have been issued. 10 Million Patents, USPTO, https://10millionpatents.uspto.gov/ (last visited Nov. 14, 2018). Scientific
journal articles are more numerous—in excess of fifty million as of 2009. Sarah Boon, 21st
Century Science Overload, CAN. SCI. PUB. (Jan. 7, 2017), http://blog.cdnsciencepub.com/
21st-century-science-overload/. Even with clever keyword searching, these are difficult to
thoroughly compare against an application in a few hours.
7.
See R. Polk Wagner, Understanding Patent-Quality Mechanisms, 157 U. PA. L.
REV. 2135, 2138 (2009) (“[G]iven the number of annual filings, it is hard to imagine any scenario in which enough resources could be directed toward this effort to have a meaningful
impact.”).
8.
See generally id. at 2145–58 (reviewing general contributors to low patent quality).
9.
Patent trolls are also commonly referred to as “nonpracticing entities” (NPEs) or
“patent assertion entities” (PAEs), among other terms. See Edward Lee, Patent Trolls: Moral
Panics, Motions In Limine, and Patent Reform, 19 STAN. TECH. L. REV. 113, 116 (2015).
10.
See Ted Sichelman, Commercializing Patents, 62 STAN. L. REV. 341, 368 (2010)
(“[N]onpracticing entities (NPEs)—namely, firms that do not commercialize their patented
inventions and perform little to no R & D—are often termed ‘patent trolls,’ because they tend
to exploit litigation and licensing market defects to extract unwarranted rents from commercializers, usually on patents that the commercializer was completely unaware of before the
NPE’s demand for payment.”).
11.
See James Bessen et al., The Private and Social Costs of Patent Trolls, 34
REGULATION 26, 26 (2011–2012); see also Mark A. Lemley, Scope, 57 WM. & MARY L.
REV. 2197, 2240–43 (2016); supra note 11.
12.
See Bessen et al., supra note 11, at 26 (finding that patent troll lawsuits “are associated with half a trillion dollars of lost wealth to defendants from 1990 through 2010”).
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less of a troll problem in Europe than in the United States, but the UPC may
13
affect troll activity. Additionally, the growth of high-tech markets in the
14
European Union may increasingly attract trolls.
Many factors empower trolls. These include the size and wealth of a
particular market, the availability of forum-shopping, the nature of feeshifting structures, the prevalence of bad patents, the expense of litigation
for patent owners, the extent of ex ante uncertainty, and the remedies avail15
able to patent owners. Certain corrective systems have emerged in response.

C. The Role of Post-Issuance Patent Review
In the face of bad patents and those who exploit them, the importance
16
of patent-issuance error-correction has been recognized. After all, the assertion of a patent that never should have been granted is wasteful. Thus, a
variety of post-issuance systems exist for review of patent validity.
A word on terminology. Here, the term “post-issuance patent review”
(PIPR) means any judicial or administrative proceeding in which the pa17
tent’s validity is reconsidered after the issuance of a patent.
Administrative PIPR procedures have been implemented in part to facilitate error-checking of bad patents and to mitigate the effects of patent
trolls. For instance, the legislative history of the America Invents Act
18
(AIA), passed in 2011, highlights fighting patent trolls as a motivating fac19
tor behind much of that legislation. Indeed, the availability of PIPR seems
20
21
both to impede patent trolls and to lower patent litigation costs.
13.
See generally Stefania Fusco, Markets and Patent Enforcement: A Comparative
Investigation of Non-Practicing Entities in the United States and Europe, 20 MICH.
TELECOMM. & TECH. L. REV. 439 (2014) (examining the extent of patent troll activity in Europe).
14.
See Andrews Bartels, European Tech Market Expected to Continue Slow Growth
Through 2018, ZDNET (Aug. 16, 2017, 13:29 PDT), http://www.zdnet.com/article/europeantech-market-will-continue-to-grow-slowly-at-around-2-in-euros/ (predicting growth, if modest, in the European technology sector).
15.
See generally Lauren Cohen et al., Patent Trolls: Evidence from Targeted Firms
(Nat’l Bureau of Econ. Research Working Paper No. 20322, April 2016),
http://www.nber.org/papers/w20322 (discussing empirical findings as to factors driving patent
trolls).
16.
See, e.g., Wagner, supra note 7, at 2161 (identifying post-issuance patent review as
a general, frequently proposed vehicle for improving patent quality).
17.
These are called, depending on the country, invalidity, revocation, or nullity actions.
18.
Leahy-Smith America Invents Act, Pub. L. No. 112-29, 125 Stat. 284 (2011).
19.
See generally Joe Matal, A Guide to the Legislative History of the America Invents
Act: Part II of II, 21 FED. CIR. B.J. 539 (2012).
20.
See Joe Mullin, New Patent Review Process Saves Billions—So Why Is It Under
Attack?, ARS TECHNICA (Sept. 19, 2017, 8:51 AM), https://arstechnica.com/tech-policy/
2017/09/new-patent-review-process-has-saved-billions-so-why-is-it-under-attack/; see also
Jason Rantanen, Inter Partes Review Statistics, PATENTLY-O (July 28, 2016),
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Enabling PIPR, in effect, recognizes that market participants are more
efficient than a disinterested, resource-limited patent office at flagging pa22
tentability issues and identifying prior art. But the structure of a given
PIPR system is highly significant. A PIPR system might be too punitive to
legitimate patent owners or too inaccessible to patent challengers. Ideally,
PIPR provides specialized mechanisms to adjudicate patent validity at low
cost with high accuracy. To accommodate legitimate patents that might be
only slightly overbroad, PIPR systems might allow amending a challenged
patent.

II. Structures of Existing Post-Issuance Patent
Review Systems in the United States and Europe
Europe and the United States have distinct procedural systems for postissuance review of patent validity. This Part explores the structure of each.
Section II.A introduces the vehicles for patent validity review in the United
States—namely, litigation and the administrative procedures available under
the America Invents Act. Section II.B introduces the systems operative in
Europe—namely, piecewise litigation under the substantive law of each
member state, as well as opposition proceedings before the European Patent
Office (EPO).

A. The United States
The validity of patents issued in the United States can be contested in
both litigation and administrative proceedings.
Litigation is not ideal for fighting patent trolls. Faced with a bad patent,
an accused infringer can seek a declaratory judgment of invalidity or argue
23
an invalidity defense. But patent trial costs are especially high, which,

https://patentlyo.com/patent/2016/07/partes-review-statistics.html (surveying patent invalidation rates in administrative patent review procedure).
21.
See, e.g., Malathi Nayak, Cost of Patent Litigation Falling Sharply, BLOOMBERG
(Aug. 10, 2017), https://www.bna.com/cost-patent-infringement-n73014463011/ (identifying
administrative review procedure as a factor in falling cost of patent litigation in the United
States).
22.
Compare Mark A. Lemley, Essay, Rational Ignorance at the Patent Office, 95 NW.
U. L. REV. 1495 (2001), with Michael Frakes & Melissa F. Wasserman, Irrational Ignorance
at the Patent Office, 72 VAND. L. REV. (forthcoming 2019).
23.
See generally 6A DONALD S. CHISUM, CHISUM ON PATENTS § 19.02 (reviewing
invalidity defenses); 8 CHISUM ON PATENTS § 21.03[4] (reviewing declaratory judgment). See
also 35 U.S.C. § 282(b)(2)–(3) (2012) (establishing grounds for invalidity defenses). A patent
owner is precluded from asserting later a patent found invalid at trial. Blonder-Tongue Labs.,
Inc. v. Univ. of Ill. Found., 402 U.S. 313, 349–50 (1971).
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coupled with high ex ante uncertainty surrounding patent validity, incentiv24
izes settlement even if the asserted patent is improper.
Under the AIA, several administrative PIPR proceedings are newly
25
available to cancel or amend a bad patent. These include several largely
similar proceedings: inter partes review (IPR), covered business method re26
view (CBMR), and post-grant review (PGR). These are all adversarial
procedures before an administrative tribunal, the Patent Trial and Appeal
Board (PTAB). Each varies—for instance, PGR is available for only nine
months after a patent issues, but the patent can be challenged on any
27
28
ground. IPR is available at almost any time, but the grounds of challenge
29
are restricted. CBMR allows a challenge on any ground but is restricted to
a narrow subset of subject-matter and is available only to parties that have
30
been sued for infringement.
Administrative PIPR procedures in the United States suffer from several perceived drawbacks. For one, their constitutional legitimacy is still being
explored—the general constitutionality of such administrative determinations of property rights was recently upheld, but the Supreme Court noted
31
an open question as to the constitutionality in certain situations. Second, in
some respects, the PTAB employs different legal standards than district
courts do, and the estoppel effect of validity judgments or determinations of
32
patent scope are uncertain. Third, while meant to be an efficiency-

24.
See, e.g., James Bessen & Michael J. Maurer, The Direct Costs from NPE Disputes,
99 CORNELL L. REV. 387, 408 (2014) (estimating the burden of litigation by patent trolls at
$29 billion annually).
25.
Leahy-Smith America Invents Act, Pub. L. No. 112-29, 125 Stat. 284 (2011).
26.
See generally 4 DONALD S. CHISUM, CHISUM ON PATENTS § 11.07 (describing
post-allowance procedures at the United States Patent and Trademark Office).
27.
See 35 U.S.C. § 321.
28.
There are some slight qualifications to availability for IPRs, which cannot be filed
sooner than nine months following patent issuance, see id. § 311(c)(1), and can only be filed
within twelve months of the suit if the filing party has been sued for infringement, see id. §
315(b).
29.
See id. § 311.
30.
See 37 C.F.R. § 42.302(a) (2017) (establishing that a CBMR petition may only be
filed by a party sued for infringement); id. § 42.303 (CBMR available any time after PGR); id.
§ 42.304 (establishing substantive grounds for challenge).
31.
See Oil States Energy Servs., LLC v. Greene’s Energy Grp., LLC, 138 S. Ct. 1365
(2018). The Court held that, under the public-rights doctrine, inter partes review by the
USPTO does not violate Article III of the U.S. Constitution. Id. at 1373; see also id. at 1379
(“[W]e address only the precise constitutional challenges that Oil States raised here. Oil States
does not challenge the retroactive application of inter partes review, even though that procedure was not in place when its patent issued.”).
32.
For instance, up until a November 2018 rule change, the PTAB and district courts
used slightly different standards in interpreting patent scope. PTAB Issues Claim Construction
Final Rule, USPTO, https://www.uspto.gov/patents-application-process/patent-trial-andappeal-board/procedures/ptab-issues-claim-construction (last visited Nov. 13, 2018). The relationship between the PTAB and district courts vis-à-vis issue preclusion is still unsettled. See
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enhancing substitute for litigation, administrative PIPR has become a rou33
tine addendum to litigation. Fourth, there is some contention that the relaxed procedural requirements and legal standards have resulted in a system
that is too aggressive in finding patents invalid and has given rise to “reverse trolling”—that is, using PIPR to extort settlements from patent own34
ers.

B. Europe
Post-issuance review of patents in Europe is more complex due to the
coexistence of multiple patent law systems, including individual national
bodies of patent law and several international agreements, most prominently
35
the European Patent Convention (EPC). An inventor may procure a patent
(1) through examination by an individual national patent office, submitted
directly in each nation in which protection is desired, yielding “national patents”; or (2) through a single application before the EPO followed by individual validation in applicant-designated EPC signatory countries, yielding
36
“European patents.” But despite a centralized examination process, a “European patent” under the EPC is really just a bundle of national patents.
There is one EPC-wide post-issuance review system, but it is very narrow. Patents issued through the EPO are subject to challenge for nine
37
months after issuance through the opposition procedure. Opposition is ad38
39
versarial and administrative; any person may file an opposition. The
grounds on which a patent may be challenged in an opposition are limited to
Jonathan I. Tietz, The “Broadest Reasonable Interpretation” and Applying Issue Preclusion
to Administrative Patent Claim Construction, 117 MICH. L. REV. 349 (2018).
33.
It is becoming common practice to file petitions for inter partes review of asserted
patents as part of a general litigation defense strategy. See, e.g., Matt Cutler, Inter Partes Review—Not
Just
an
Anti-Troll
Proceeding,
LAW360
(July
21,
2015),
https://www.law360.com/articles/679716/inter-partes-review-not-just-an-anti-troll-proceeding
(describing such strategy).
34.
See Erik Hovenkamp & Jorge Lemus, Delayed Entry Settlements at the Patent Office, 54 INT’L REV. L. & ECON. 30 (2018).
35.
Convention on the Grant of European Patents of 5 October 1973 (European Patent
Convention), http://www.epo.org/patents/law/legal-texts/epc.html [hereinafter EPC]. The
membership of the EPC includes all Member States of the European Union as well as several
non-EU countries. Joseph Kenneth Yarsky, Note, Hastening Harmonization in European Union Patent Law Through a Preliminary Reference Power, 40 B.C. INT’L & COMP. L. REV.
167, 173 (2017).
36.
EPC, supra note 35, art. 65(1) (“Any Contracting State may . . . prescribe that the
proprietor of the patent shall supply to its central industrial property office a translation of the
patent . . . in one of its official languages . . . .”).
37.
Id. art. 99. The grounds of patentability are limited to EPC articles 52–57—
essentially, subject matter, novelty, inventive step, and industrial application. See also Oppositions, EUR. PATENT OFFICE (last updated Oct. 4, 2017), https://www.epo.org/
applying/european/oppositions.html.
38.
EPC, supra note 35, art. 99.
39.
Id. art. 99(3).
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patentability (including subject matter, novelty, inventive step), incomplete
40
disclosure, and improper support for amendments.
Beyond the nine-month window for bringing an opposition, the EPC allows for limitation (i.e., amendment) or revocation (i.e., invalidation) of a
European patent before the EPO, which, if successful, are effective in all
41
applicable countries. But only a patent owner can seek limitation or revo42
cation. Hence, this is not an effective anti-troll PIPR vehicle but simply a
low-risk way for a patent owner to proactively narrow the scope of a questionable patent.
Thus, given the limits of EPO opposition, limitation, and revocation
proceedings, the main way to conduct PIPR of a bad patent in Europe is
country-by-country litigation. Despite some harmonization of substantive
43
patent law across Europe, however, litigation procedures vary in ways that
can affect troll behavior.
There is variation across the European Union as to who is entitled to request review of validity of a patent. France, for instance, has strict requirements that a party seeking invalidity must possess “sufficient interest to free
the patented technique from any patent protection and demonstrate that the
44
patent is an actual threat to its economic activity.” In contrast, German law
45
permits any party to bring an action for invalidity, as does the law of the
46
United Kingdom. In general, invalidity actions are permissive; only a
handful of European Union member states appear to have meaningful stand47
ing requirements. There is also variation as to whether infringement and
40.
Id. art. 100.
41.
Id. art. 105a.
42.
Id. art. 105a(1).
43.
See Yarsky, supra note 35, at 168–73 (recounting the history of patent law harmonization efforts in Europe, including the European Patent Convention in 1977).
44.
See Thomas Bouvet & Isabelle Bertaux, French Court Rules on Patent Revocation
Interest to Sue, Statutes of Limitation, JONES DAY (July 19, 2017), http://www.jonesday.com/
french-court-rules-on-patent-revocation-interest-to-sue-statutes-of-limitation-07-19-2017/.
45.
See EUROPEAN PATENT ACADEMY, PATENT LITIGATION IN EUROPE 33–34 (4th ed.
2016), https://www.epo.org/learning-events/materials/litigation.html [hereinafter PATENT
LITIGATION IN EUROPE].
46.
See id. at 52.
47.
Sweden, for example, allows any person who has suffered damage or a government-designated authority to bring such an action. See id. at 117. Finland limits availability to
a “person who suffers prejudice on account of the patent” but also allows “a public authority
appointed by the government for reasons of public interest.” Id. at 45. A few nations, including Slovenia, provide that “any interested party” may bring an invalidity action. Id. at 121.
The phrasing in the laws of Greece, Hungary, Italy, Lithuania, and Portugal are similar. See
generally id. In general, however, most countries allow any party to bring such an action
through some procedure, whether administrative or judicial. See generally id. This is because
invalidity review is often left to administrative agencies. Id.; see also Mark A. Lemley, Why
Do Juries Decide if Patents Are Valid?, 90 VA. L. REV. 1673, 1732 (2013) (observing that “in
many other countries, like Germany, validity and infringement are entirely separate, with the
courts resolving only infringement and leaving validity review to the technical boards of appeal within the patent office”) [hereinafter Lemley, Why Do Juries Decide?].
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validity issues are tried together (as in the United Kingdom) or separately
48
(i.e., “bifurcation,” as in Germany).
Substantive law differs too. The interpretation of each ground on which
49
a patent may be revoked is a matter of national law. For instance, in comparing two otherwise identical patents with the same prior art, the laws of
one country might interpret certain terminology differently than another
country. Or these laws might evaluate different factors in judicial tests for
novelty or obviousness, leading to a nation-by-nation patchwork of validity.
Accordingly, a party seeking to subject a bad patent to PIPR must do so
in individual countries with variations in substantive and procedural law—
50
heightening both economic and legal uncertainty ex ante. There exists no
international PIPR option in Europe. The anticipated UPC system, however,
will change this, as discussed next.

III. The European Union’s Unified Patent Court (UPC)
This Part examines the structure of post-issuance patent review under
the European Union’s unitary patent system. Section III.A briefly reviews
the status of the Unified Patent Court (UPC). Section III.B describes its
general structure. Section III.C concentrates on the aspects of the UPC relevant to PIPR.

48.
See Katrin Cremers et al., Invalid but Infringed? An Analysis of the Bifurcated Patent Litigation System, 131 J. ECON. BEHAVIOR & ORGANIZATION 218, 219, 240–41 (2014)
(finding that whether or not a system is bifurcated affects the likelihood of challenge of validity and likelihood of settlement). This has implications for the effectiveness of PIPR—first,
remedies may become prematurely available to a patent troll if an infringement proceeding is
resolved before a validity proceeding; and second, in a bifurcated action the owner of a bad
patent is free to pursue a broad interpretation of the patent’s scope in an infringement proceeding while pursuing a narrower interpretation during review of validity, undermining the usefulness of an invalidity action as a means of PIPR. See Lemley, Why Do Juries Decide?, supra note 47, at 1732 (noting that “bifurcation [] raises the risk that a patent claim will be
treated ‘like a nose of wax which may be turned and twisted in any direction,’ with both parties urging inconsistent positions before different tribunals depending on whether the issue is
validity or infringement”).
49.
See EPC, supra note 35, art. 2(2) (“The European patent shall, in each of the Contracting States for which it is granted, have the effect of and be subject to the same conditions
as a national patent granted by that State, unless this Convention provides otherwise.”); id. art.
74 (“Unless this Convention provides otherwise, the European patent application as an object
of property shall, in each designated Contracting State and with effect for such State, be subject to the law applicable in that State to national patent applications.”).
50.
See, e.g., Yarsky, supra note 35, at 170 (“The authority of national courts to hear
cases of validity and infringement leads to inconsistent results among states and uncertainty
when an inventor seeks to protect her intellectual property rights.”).
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A. The Status of the UPC
A new unitary patent system is the subject of an agreement (the UPCA)
51
between most of the EU Member States. The UPCA establishes the UPC,
52
which has competence over European patents and “unitary patents.” Unlike European patents, unitary patents are essentially single European Un53
ion–wide intellectual property rights. The preamble to the UPCA lists as a
54
foundational goal enhancing the revocation of improper patents. Additionally, the Commission has opined that the UPC will not be amenable to pa55
tent troll behavior.
The signatory states (twenty-five European Union member states, excluding Croatia, Poland, and Spain) signed the UPCA on February 19,
56
2013. This followed in the wake of two enabling “enhanced cooperation”
57
regulations that authorized unitary patents. Sixteen states have now ratified
58
the UPCA, and the EPO expects that the UPC will begin operating in the
59
first half of 2019.

51.
Agreement on a Unified Patent Court, 2013 O.J. (C 175) 1 [hereinafter UPCA];
About the UPC, UNIFIED PATENT COURT, https://www.unified-patent-court.org/ (last visited
May 7, 2019).
52.
Id. at 2–3. Unitary patents are also known as “European patents with unitary effect,” or EPUEs. See id. art. 2(f).
53.
With the exception of a few Member States not a party to the UPCA.
54.
UPCA, supra note 51, at 1 (“WISHING to improve the enforcement of patents and
the defense against unfounded claims and patents which should be revoked and to enhance
legal certainty by setting up a Unified Patent Court for litigation relating to the infringement
and validity of patents;”).
55.
See Written Question by Members of the European Parliament and their Answers
Given by a European Union Institution, 2014 O.J. (C 221) 307 (“The Commission fails to see
how the recent Union legislation on patents, namely Regulations 1257/2012 and 1260/2012,
could increase the activity of so called ‘patent trolls’ in Europe. . . . The UPC Agreement provides for safeguards against ‘patent trolls’. . . . The objective is to ensure that the patent validity is dealt with before the infringement action can proceed.”).
56.
PATENT LITIGATION IN EUROPE, supra note 45, at 135; Establishment of the Unified Patent Court (UPC), HERBERT SMITH FREEHILLS (Apr. 30, 2018),
https://www.herbertsmithfreehills.com/latest-thinking/unified-patent-court-agreementincluding-signatories-and-ratification.
57.
Regulation 1257/2012 of the European Parliament and of the Council of 17 December 2012, Implementing Enhanced Cooperation in the Area of the Creation of Unitary
Patent Protection, 2012 O.J. (L 361); Council Regulation 1260/2012, Implementing Enhanced
Cooperation in the Area of the Creation of Unitary Patent Protection with Regard to the Applicable Translation Arrangements, 2012 O.J. (L 361) 89; see also Markus B. Boelling &
Thomas Koerfer, Unitary Patent Protection in Europe—An Attunement on the Upcoming New
System, 42 AIPLA Q.J. 493, 497–501 (2014) (discussing these regulations).
58.
See Agreement on a Unified Patent Court (UPC) – Ratification Details, GENERAL
SECRETARIAT
OF
THE
COUNCIL,
http://www.consilium.europa.eu/en/documentspublications/treaties-agreements/agreement/?id=2013001 (last visited Sept. 28, 2018).
59.
When Will the Unitary Patent System Start?, EUR. PATENT OFFICE,
https://www.epo.org/law-practice/unitary/unitary-patent/start.html (last visited Sept. 28,
2018).
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The UPC’s legality has been questioned, but the Court of Justice has so
far found it to be compatible with European Union law. Namely, Spain in
2013 unsuccessfully challenged the two unitary-patent regulations on
grounds of lack of judicial review, impermissible delegation, and discrimi60
nation on the basis of language. Recently, a complainant in Germany has
challenged the country’s own implementing legislation, delaying the
61
UPCA’s formal ratification. Because the complaint alleges incompatibility
of the UPC with European Union law, it is likely that the German constitutional court will refer at least one question to the Court of Justice, further
62
delaying implementation, although the court might consider the question
to have been already answered under the acte clair doctrine, considering

60.
In Case C-146/13, Spain v. European Parliament, 2015 WL Celex No. 613CJ0146,
Spain challenged Regulation 1257/2012 (implementing enhanced cooperation in the area of
the creation of unitary patent protection) on the grounds of “infringement of the values of the
rule of law,” a “lack of legal basis,” a “misuse of powers,” “infringement of Article 291(2)
TFEU and . . . Meroni v High Authority,” “infringement of those principles owing to the delegation to the EPO of certain administrative tasks relating to the EPUE,” and “infringement of
the principles of autonomy and uniform application of EU law.” Id. ¶ 23. Spain had argued
principally that the Unitary Patent system was not subject to judicial review, threatening the
uniform application of Union law and the protection of fundamental rights. Id. ¶ 24. Spain
objected also to the procedures under which fees were set and argued that the EU had impermissibly delegated power contrary to the Meroni doctrine. The Court pointed out that the EU
is not a party to the European Patent Convention or the UPCA, id. ¶¶ 82, 85, that the procedure for granting European patents had not been incorporated into EU law, id. ¶ 30, that the
Court does not have jurisdiction to rule on the lawfulness of an international agreement concluded by the member states, id. ¶ 101, and that the EU itself had not delegated any exclusive
power, id. ¶ 87.
The challenge under Case C-147/13, Spain v. Council, 2015 WL Celex No. 613CJ0147
(concerning the translation arrangements) was similar. There, Spain mainly alleged infringement of the principle of non-discrimination on the ground of language, given certain language
restrictions at the UPC. Id. ¶¶ 22–25. The Court found, however, that such language discrimination was justified—satisfying proportionality analysis—by the legitimate objective of creation of a uniform and simple translation regime so as to facilitate access to patent protection
by making the patent system simpler, less costly, and legally more secure. Id. ¶¶ 31–48.
61.
A decision has not been reached, and few case details are public. See Thosten
Bausch, UPC – Finally some News from the German Federal Constitutional Court, KLUWER
PATENT BLOG (Aug. 16, 2017), http://patentblog.kluweriplaw.com/2017/08/16/upc-finallysome-news-from-the-german-federal-constitutional-court/; Richard Pinckney, Complainant in
UPC German Constitutional Challenge Publishes Update, BRISTOWS UPC (Mar. 7, 2018),
https://www.bristowsupc.com/latest-news/complainant-in-upc-german-constitutionalchallenge-publishes-update/. But in an interesting parallel to common criticisms of administrative post-issuance patent review (e.g., IPR) in the United States, the challenge includes allegations of insufficient procedural safeguards and a lack of judicial independence in the UPC
system. See Alexander Klicznik & Lukas Sievers, UPC and Germany: Status Update - Constitutional Complaint, Ratification Timeline and More, LEXOLOGY (Oct. 17, 2017),
https://www.lexology.com/library/detail.aspx?g=bfe0c73a-8b0e-4e37-9efd-f1407e3e9a92.
62.
See European Patent Institute, What We Know About the Status of the Unitary Patent and Unified Patent Court Project in Mid September 2017, EPI INFORMATION (Sept.
2017), https://information.patentepi.com/issue-3-2017/what-we-know-about-the-status-of-theunitary-patent-and-unified-patent-court-project-in-mid-september-2017.html.
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64

Spain’s litigation. This and Brexit stand as the last roadblocks to implementation.

B. General Structure of the UPC
The UPC is an international legal system resembling a specialized hybrid of a patent agency and a court.
The UPC “shall be a court common to the Contracting Member States
and thus subject to the same obligations under Union law as any national
65
court of the Contracting Member States.” The UPC draws from European
Union law, among other sources, although it is not a European Union
66
body. Several specific sources of law are explicitly applicable, namely Eu67
ropean Union law, including the two enhanced-cooperation regulations;
the UPCA itself; the EPC; applicable international agreements; and national
68
law in certain circumstances. The contractual and noncontractual liability
of the UPCA is expressly governed not only by contracting member state
69
law but also by European Union regulations. Indeed, Article 20 declares
that “[t]he Court shall apply Union law in its entirety and shall respect its
70
71
primacy,” and the UPC is bound by decisions of the Court of Justice.
The UPCA establishes a centralized system not only for patent examination but also for litigation, hearing claims and counterclaims for in72
fringement and validity (under the UPCA, “revocation”). The court comprises a Court of First Instance (CFI) (with central, regional, and local
73
divisions) and a Court of Appeal.

63.
See supra note 60.
64.
See PATENT LITIGATION IN EUROPE, supra note 45, at 135.
65.
UPCA, supra note 51, art. 1; see also id. art. 4(1) (“The Court shall have legal personality in each Contracting Member State and shall enjoy the most extensive legal capacity
accorded to legal persons under the national law of that State.”).
66.
Id. art. 24. Although the unitary patent is affirmatively authorized by the European
Patent Convention (EPC), see EPC, supra note 35, art. 142, Unified Patent Court and the unitary patent system are available only to European Union member states and not to non-EU
EPC signatories. See Boelling & Koerfer, supra note 57, at 497.
67.
Regulation 1257/2012 of the European Parliament and of the Council of 17 December 2012, Implementing Enhanced Cooperation in the Area of the Creation of Unitary
Patent Protection, 2012 O.J. (L 361); Council Regulation 1260/2012, Implementing Enhanced
Cooperation in the Area of the Creation of Unitary Patent Protection with Regard to the Applicable Translation Arrangements, 2012 O.J. (L 361) 89.
68.
UPCA, supra note 51, art. 24.
69.
See id. art. 5.
70.
Id. art. 20.
71.
Id. art. 21.
72.
Id. arts. 32, 65.
73.
Id. arts. 6(1), 7(1). The central division is to be seated in Paris, with sections also in
London and Munich. Id. art. 7(2). The continued presence of the London section is especially
intriguing in light of Brexit. Regional divisions are to be established for groups of Contracting
States, whereas local divisions are specific to individual Contracting States. Id. arts. 7(3)–(5).
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In general, the judicial panels of the CFI resemble those of an ordinary,
if specialized, court. The UPCA establishes two categories of judges: legal74
ly qualified and technically qualified. Members of the former are required
to “possess the qualifications required for appointment to judicial offices in
a Contracting Member State”; the latter must have “a university degree and
proven expertise in a field of technology” and have “proven knowledge of
75
civil law and procedure relevant in patent litigation.” Both must have
76
“proven experience in the field of patent litigation.”
By default, panels of the local and regional divisions are obligatorily
77
78
multinational and entirely comprise legally qualified judges. Panels may
request allocation of one technically qualified judge sua sponte or at the re79
quest of a party. Additionally, where patent validity is in question—
revocation actions or counterclaims—a technically qualified judge is typi80
cally required. Panels of the central division, which has exclusive jurisdiction over stand-alone revocation claims, consist of two legally qualified and
81
one technically qualified judge. Panels of the Court of Appeal are also
multinational and comprise five judges: three legally qualified and two
82
technically qualified.
Thus, although for infringement claims it resembles an ordinary, if specialized, court, for revocation claims (where the questions at hand are particularly technical) the UPC begins to resemble a specialized administrative
83
body.

C. Post-Issuance Patent Review under the UPCA
The vehicle for post-issuance error-checking under the UPCA is the
revocation action, which may be brought either for unitary or European pa-

74.
Id. art. 15(1).
75.
Id. arts. 15(2), 15(3).
76.
Id. art. 15(1).
77.
Id. art. 8(1).
78.
Id. arts. 8(3), 8(4).
79.
Id. art. 8(5).
80.
Id. art. 33(3)(a). Parties may, alternatively, simply agree to be heard by a single
legally qualified judge in lieu of such a panel. Id. art. 8(7).
81.
Id. art. 8(6).
82.
Id. art. 9(1).
83.
Compare, for instance, to the United States: in patent litigation, neither the judge
nor any of the litigating attorneys need have any meaningful technical qualifications; in administrative review proceedings before the Patent Trial and Appeal Board, however, the judges are usually technically qualified (often with work experience or graduate education), and
the attorneys must be admitted to practice before the USPTO—that is, having passed a patentspecific registration exam and possessing certain technical education qualifications. See
Saurabh Vishnubhakatet al., Strategic Decision Making in Dual PTAB and District Court
Proceedings, 31 BERKELEY TECH. L.J. 45, 52–54 (2016) (comparing district court judges and
administrative patent judges and the contribution of the difference to forum-shopping in district courts).
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84

tents. The UPC has a limited period of concurrent jurisdiction with nation85
al courts for review of European patents but has exclusive jurisdiction over
86
unitary patents. The UPC has no jurisdiction over national patents.
Grounds for revocation are expressly enumerated and include subject
matter, novelty, inventive step, definiteness, industrial application, adequate
87
disclosure, among others. This essentially equates the standards for revocation actions and patent examination.
88
The UPCA imparts no timing requirement for revocation actions, in
89
contrast to the EPO’s nine-month window for oppositions and the UPCA’s
90
five-year limitations period for monetary-damages actions.
Importantly, a revocation action is not a binary, valid-or-invalid inquiry. Rather, the UPCA imparts a patent limitation requirement in revoca91
tion proceedings. If only a part of a patent is deemed invalid, the patent is
modified accordingly by amendment rather than being struck down entirely.
92
This Article 65(3) requirement is couched as a mandate upon the court,
and it is nearly identical to its counterpart in the EPC concerning revocation
93
actions at the EPO. These requirements cooperate with EPC Article
138(3), which gives patent owners the right to limit by amendment a patent
94
whose validity is before a competent authority.
The forum for a revocation action is limited. UPCA Article 33 estab95
lishes the competence of the Court of First Instance (CFI), in which stand96
alone revocation actions are limited to the central division. If a parallel infringement proceeding is pending, the revocation action is to be brought in

84.
UPCA, supra note 51, art. 32(1)(d).
85.
Id. art. 83(1) (establishing seven-year transitional period of concurrent jurisdiction).
86.
Id. art. 32(1).
87.
Id. art. 65(2). These are defined by reference to the EPC and are equivalent to the
patentability grounds described therein.
88.
Id. art. 32(1)(d), (e).
89.
EPC, supra note 35, art. 99(1).
90.
UPCA, supra note 51, art. 72 (“[A]ctions relating to all forms of financial compensation may not be brought more than five years after the date on which the applicant became
aware, or had reasonable grounds to become aware, of the last fact justifying the action.”).
91.
Id. art. 65(3).
92.
Id. art. 65(3) (“Without prejudice to Article 138(3) of the EPC, if the grounds for
revocation affect the patent only in part, the patent shall be limited by a corresponding
amendment of the claims and revoked in part.” (emphasis added)).
93.
EPC, supra note 35, art. 138(2) (“If the grounds for revocation affect the European
patent only in part, the patent shall be limited by a corresponding amendment of the claims
and revoked in part.” (emphasis added)).
94.
Id. art. 138(3) (“In proceedings before the competent court or authority relating to
the validity of the European patent, the proprietor of the patent shall have the right to limit the
patent by amending the claims. The patent as thus limited shall form the basis for the proceedings.”).
95.
UPCA, supra note 51, art. 33.
96.
Id. art. 33(4).
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97

the same local or regional division; this is true also of revocation counter98
claims. A local or regional division, however, has the discretion to refer
99
the revocation to the central division. Where a local or regional division
keeps the revocation action, it must also request allocation of a technically
100
qualified judge from a centralized pool. This transforms the panel into one
resembling the central division.
The UPCA authorizes not only revocation counterclaims but direct rev101
ocation actions themselves. Curiously, it is unclear exactly who is entitled
102
to bring such an action. Article 47(6) provides:
Any other natural or legal person, or any body entitled to bring actions in accordance with its national law, who is concerned by a patent, may bring actions in accordance with the Rules of Procedure.
103

The meaning of “who is concerned by a patent”
is not clear, but
comparison to the phrasing of the rules for opposition before the EPO sug104
gests that it is perhaps stricter than the EPO’s “any person” —especially
because other language in the UPCA was seemingly directly imported from
105
the EPC. The EPC provides:
Within nine months of the publication of the mention of the grant
of the European patent in the European Patent Bulletin, any person
may give notice to the European Patent Office of opposition to that
patent, in accordance with the Implementing Regulations. . . .
The Draft Rules of Procedure for the UPC do not directly address
106
standing. Despite the phrase “who is concerned by a patent” in Article

97.
98.
99.
100.
101.
102.
103.

Id.
Id. art. 33(3).
Id.
Id. art. 33(3)(a).
Id. art. 32(1)(d) (establishing competence for revocation actions).
Id. art. 47(6) (emphasis added).
The German version of the UPCA uses the word “betroffen”:

(6) Jede andere natürliche oder juristische Person oder jede Vereinigung, die von
einem Patent betroffen und nach dem für sie geltenden nationalen Recht berechtigt
ist, Klage zu erheben, kann nach Maßgabe der Verfahrensordnung Klage erheben.
The French uses “concerné”:
6. Toute autre personne physique ou morale, ou tout organisme habilité à engager
une action conformément à son droit national, qui est concerné par un brevet, peut
engager une action conformément au règlement de procédure.
See 2013 O.J. EPO 287, 319, http://archive.epo.org/epo/pubs/oj013/05_13/05_2873.pdf.
104.
EPC, supra note 35, art. 99(1).
105.
Id. (emphasis added).
106.
See generally Preliminary Set of Provisions for the Rules of Procedure of the Unified Patent Court, 18th Draft of Oct. 19, 2015 (Mar. 15, 2017), https://www.unified-patent-
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47(6)—hinting at a requirement of economic or legal interest—the requirements for a “statement for revocation” in the Draft Rules include no re107
quirement of a statement of concern or a demonstration of interest. In contrast, for patent infringement, the Rules affirmatively require filing evidence
that the claimant, if not the patent owner, is “entitled to commence proceed108
A similar requirement is found for a declaration of nonings.”
109
infringement.
Other European Union law does not clearly resolve the issue. The Unitary Patent Regulation (UPR) includes some provisions detailing when national law applies. Article 7, for instance, specifies which national law applies to a given unitary patent based on the applicant’s residency or
110
business, treating the patent as an object of property in that jurisdiction.
Article 5(3), in turn, seems to base the scope of protection and limitations
111
on the national law designated by Article 7. As noted, individual countries
112
differ in who is permitted to bring a revocation action under national law,
and so if national law is the determinant of who may bring a revocation action at the UPC, a patchwork will result, in tension with Article 5(2)’s em113
phasis on uniform scope. Indeed, under the UPCA, revocation is largely
court.org/sites/default/files/upc_rules_of_procedure_18th_draft_15_march_2017_final_clear.
pdf [hereinafter Draft Rules of Procedure].
107.
See id. r. 44.
108.
See id. r. 13.1(f) (requiring when stating an infringement claim “where the claimant
is not the proprietor of the patent concerned, or not the only proprietor, evidence to show the
claimant is entitled to commence proceedings”). Rule 13.1 contains a number of other pleading requirements. Rule 44, which governs pleading of revocation actions, includes some of the
Rule 13.1 requirements, but conspicuously omits 13.1(f). See id. r. 44.
109.
See id. r. 63(a) (requiring the particulars of Rule 13.1, including evidence to show
the claimant is entitled to commence proceedings).
110.
Regulation 1257/2012 of the European Parliament and of the Council of 17 December 2012, Implementing Enhanced Cooperation in the Area of the Creation of Unitary
Patent Protection, 2012 O.J. (L 361) 5, art. 7(1) [hereinafter Unitary Patent Regulation] (“A
European patent with unitary effect as an object of property shall be treated in its entirety and
in all the participating Member States as a national patent of the participating Member State in
which that patent has unitary effect and in which, according to the European Patent Register . . . the applicant had his residence or principal place of business . . . or [] where . . . the
applicant had a place of business on the date of filing.”); see also id. art. 7(3) (providing that
German national law applies if an applicant has no residence or business in a Contracting
State).
111.
See id. art. 5(3) (“The acts against which the patent provides protection referred to
in paragraph 1 and the applicable limitations shall be those defined by the law applied to European patents with unitary effect in the participating Member State whose national law is
applicable to the European patent with unitary effect as an object of property in accordance
with Article 7.”). Article 5(3) might, instead, be narrow—it specifies that the applicable law is
“the law applied to European patents with unitary effect in the participating Member State
whose national law is applicable,” which seems to suggest law implementing the unitary patent system. See id.
112.
See supra text accompanying notes 44–48.
113.
See Unitary Patent Regulation, supra note 111, art. 5(2) (emphasizing that “[t]he
scope of [the unitary patent] right and its limitations shall be uniform in all participating
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centralized, suggesting that national law should not apply in this respect, so
as not to undermine the effectiveness of such centralization. Further, the
UPC’s structure resembles the German patent system, German law applies
114
when no particular national law clearly applies, and under German law,
any party may bring revocation. Thus, it is probably appropriate to read Article 7 as regarding substantive, not procedural, patent law—there only to
115
fill gaps in the UPCA.
The “concerned by” language of Article 47 evokes the concepts of di116
rect and individual concern in European Union law. Given that European
Union law has primacy under the UPCA, these concepts might be import117
ed. If so, however, it is still puzzling that the Draft Rules of Procedure for
the UPC contain requirements for detailed pleading of grounds of unpatentability in a revocation action but no requirement of a statement of concern.
118
Article 42 also imposes proportionality and fairness requirements.
Perhaps allowing any party—regardless of economic or legal interest—to
bring a revocation action at any time in the lifetime of a patent might run
119
afoul of fairness, as property stands to be taken away. Consider Article
69, which establishes that the losing party in an action before the UPC will
120
bear the legal costs of the winner. If any party, regardless of legal or eco-

Member States in which the patent has unitary effect”). On the other hand, these “rights and
limitations” are likely those outlined in UPCA arts. 25–30, delineating the rights of a patent
owner to exclude others from practicing an invention and providing limitations on who the
patent owner may exclude. See UPCA supra note 52, arts. 25–30. These provisions do not
address the separate issue of what the scope of the technology covered by the patent—and the
conditions of its issuance—are. See id.
114.
See Case C-146/13, Spain v. European Parliament, 2015 WL Celex No.
613CJ0146, ¶ 16.
115.
For example, questions of patent claim term interpretation, findings of facts, and
the like.
116.
See, e.g., Consolidated Version of the Treaty on the Functioning of the European
Union art. 263, Oct. 26, 2012, 2012 O.J. (C 326) 162 [hereinafter TFEU] (“Any natural or
legal person may, under the conditions laid down in the first and second paragraphs, institute
proceedings against an act addressed to that person or which is of direct and individual concern to them, and against a regulatory act which is of direct concern to them and does not entail implementing measures.”).
117.
See UPCA, supra note 51, art. 20 (“The Court shall apply Union law in its entirety
and shall respect its primacy.”).
118.
Id. art. 42.
119.
See, e.g., Anje Lunze & Jan Phillip Rektorschek, Can You Afford to Litigate in the
Unified Patent Court?, MANAGING IP (Aug. 25, 2015), http://www.managingip.com/Article/
3480083/Can-you-afford-to-litigate-in-the-Unified-Patent-Court.html, also available at
https://deutschland.taylorwessing.com/documents/get/194/can-you-afford-to-litigate-in-theupc.pdf (warning potential patent clients of the risk of exposure to legal fees via revocation
filings by third parties).
120.
UPCA, supra note 51, art. 69(1) (“Reasonable and proportionate legal costs and
other expenses incurred by the successful party shall, as a general rule, be borne by the unsuccessful party, unless equity requires otherwise, up to a ceiling set in accordance with the Rules
of Procedure.”).
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nomic interest, may institute a revocation action, this may be unfair under
121
Article 42 (especially if a patent owner never intended to assert its patent).
On the other hand, the UPC might decline to fee-shift in such a situation
122
under the equitable exception in Article 69.
The European Patent Convention—from which much of UPC law is
imported—does not clarify. The EPC delineates its impact on national law
123
but has no provision describing standing.
There is another way to read Article 47(6): the phrase “who is concerned by a patent” might be read to modify only the phrase “any body enti124
tled to bring actions in accordance with . . . national law.” In that case,
“concerned by a patent” seems to impose a requirement that governmental
bodies (as opposed to individuals and private juridical entities) who bring
125
revocation actions have some relation to patent law. For example, a designated public prosecutor (or perhaps an official acting on behalf of a country’s patent office) who deals with patents could bring a revocation action
on behalf of the government, but a local magistrate could not. This would be
consistent with the current practices of certain UPCA signatories—for ex126
ample, Finland, Italy, and Sweden. This also appears to be consistent with
127
the grammatical structure of the German version of Article 47(6).
Thus, the exact threshold for revocation standing seems unclear, but,
given that revocation is intended to be a centralized procedure surrounding a
121.
See id. art. 42.
122.
Id. art. 69.
123.
EPC, supra note 35, art. 138.
124.
UPCA, supra note 51, art. 47(6) (“Any other natural or legal person, or any body
entitled to bring actions in accordance with its national law, who is concerned by a patent,
may bring actions in accordance with the Rules of Procedure.” (emphasis added)).
But it is unclear under this reading why Article 47(6) was not worded as clearly as Article 47(7):
Any natural or legal person, or any body entitled to bring actions in accordance
with its national law and who is affected by a decision of the European Patent . . .
entitled to bring actions under Article 32(1)(i).
UPCA, supra note 51, art. 47(7) (emphasis added).
125.
For example, regarding a patent, the patent office is the agency concerned—not the
post office.
126.
See PATENT LITIGATION IN EUROPE, supra note 45, at 45, 71, 117. Sweden allows
an action by “a public authority designated by the government.” Id. at 117. Italy allows an
action by “a public prosecutor.” Id. at 71. Finland permits actions by “a public authority appointed by the government for reasons of public interest.” Id. at 45.
127.
See supra note 103 (“Jede andere natürliche oder juristische Person oder jede Vereinigung, die von einem Patent betroffen und nach dem für sie geltenden nationalen Recht
berechtigt ist, Klage zu erheben, kann nach Maßgabe der Verfahrensordnung Klage erheben.”
(emphasis added)). The phrase “die . . . berechtigt ist,” which includes the interest requirement
and the national authorization requirement, seems to modify “jede Vereinigung.” The translation would then be: “Any other natural or legal person or any association concerned by a patent and entitled to bring an action under its national law may bring an action in accordance
with the Rules of Procedure.”
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unified patent right, the requirement is likely to be uniform. Given the absence of a requirement in the Draft Rules of Procedure to demonstrate concern, the standard—if any—is likely to be modest, and perhaps only applied
to governmental plaintiffs. The UPC might simply apply its principles of
fairness and equity and examine whether the action is in bad faith. It is plausible that the mandatory fixed fee to bring a revocation action acts as a
proxy for standing to dissuade frivolous claims and indirectly assure some
128
economic interest.

IV. Comparison of the UPC and US PIPR Through the
Lens of the Patent Troll Problem
On the surface, it appears that the UPC includes a much more effective
anti-patent-troll PIPR mechanism than the United States does. But this depends on the weight of certain structural disincentives within the UPC. This
Part compares the UPC to the United States through the lens of the patent
troll problem. Section IV.A notes that, under a structural analysis, the UPC
seems to be a more expansive and accessible PIPR mechanism than exists in
the United States. Section IV.B considers that not every patent troll–
asserted patent in Europe will be a unitary patent, and so certain structural
features might dissuade patent owners from participating in the UPC at all
and hence limit its effectiveness as an anti-troll procedure.

A. The UPC Promises a Much More Expansive Post-Issuance
Patent Review System
The UPC appears to be more effective against trolls than the US system
because of advantages in availability, judicial expertise, unification of
standards, amendment practice, and forum limitations. In this sense, the
UPC appears to be a much more vigorous PIPR system.
In many respects, the UPC resembles a structural hybrid of the US litigation and administrative PIPR systems. But more importantly, it is broader
than both in overall availability—apparently, nearly any party may bring a
revocation action, and at any time, and on nearly any ground of unpatentability.
Compared to administrative PIPR in the United States, the UPC revocation proceeding is generally broader and more accessible: it is available on

128.
See PREPARATORY COMMITTEE FOR THE UNIFIED PATENT COURT, RULES ON
COURT FEES AND RECOVERABLE COSTS 9 (Feb. 25, 2016), https://www.unified-patentcourt.org/sites/default/files/agreed_and_final_r370_subject_to_legal_scrubbing_to_secretariat
.pdf [hereinafter RULES ON COURT FEES].
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more grounds than IPR, to more parties than CBMR, and for a longer
131
time than PGR.
Additionally, a UPC judgment is more direct than an administrative decision in the United States, where trial courts are generally not bound by
132
PTAB decisions not yet affirmed by the Federal Circuit. The UPC also
has exclusive competence on revocation actions for unitary patents—in the
United States, the PTAB shares its invalidation power with district courts;
133
thus, the UPC minimizes forum-based uncertainty in PIPR.
Indeed, the technical-judge allocation procedure of the UPC also seems
134
to limit the effects of forum shopping by patent troll plaintiffs. In the
United States, by contrast, the effectiveness of PIPR can be attenuated by
135
forum shopping by a savvy troll plaintiff. The UPCA’s rules that, if revocation questions arise, judges from a centralized pool are allocated to those
proceedings mean that with respect to questions of patent validity, a troll
136
plaintiff has little forum choice. Additionally, the UPC’s Draft Rules note
that where a revocation and infringement action are being tried separately,
137
the revocation claim is to be accelerated.
Additionally, amendment of a bad patent during the proceeding is man138
datory where feasible. Although in PIPR actions in the United States a
party may, in theory, amend its own patent, the PTAB typically does not

129.
See 35 U.S.C. § 311(b) (2012) (limiting IPR petitions to “only on a ground that
could be raised under [statutory novelty or obviousness] and only on the basis of prior art consisting of patents or printed publications”).
130.
See 37 C.F.R. § 42.302(a) (2017) (limiting CBMR petitions to parties having been
“sued for infringement of the patent or . . . charged with infringement under that patent”).
131.
See 35 U.S.C. § 321(c) (limiting PGR petitions to “9 months after the date of the
grant of the patent”).
132.
E.g., id. § 318(b) (establishing that the Patent Office Director only issues certificates of cancellation after both a PTAB decision and an exhaustion of any appeal); Rembrandt
Wireless Techs., LP v. Samsung Elecs. Co., 853 F.3d 1370, 1377 (Fed. Cir. 2017) (noting that
PTAB decisions are not generally binding on district courts). This has led to situations where
a patent is simultaneously (and paradoxically) held valid in one tribunal and invalid in another. See, e.g., Tietz, supra note 32, at 353–61.
133.
With respect to unitary patents, that is, and some European patents. National patents remain in place.
134.
Brian Jacobsmeyer, Note, Forum Shopping in Patent Cases: Lessons for the Unified Patent Court, 25 MICH. TECH. L. REV. 131, 151 (2019).
135.
See J. Jonas Anderson, Court Competition for Patent Cases, 163 U. PA. L. REV.
631, 646–51 (2015) (noting that in the 1970s, “the odds of having a patent found to be valid
could differ by over fifty percent, depending on the circuit court that ultimately reviewed the
case” and observing that even since the creation of a unified circuit court with exclusive subject-matter jurisdiction over patent cases, “forum shopping persists”); see also Kimberly A.
Moore, Forum Shopping in Patent Cases: Does Geographic Choice Affect Innovation?, 79
N.C. L. REV. 889, 921–22 (observing that “forum and timing really do matter”).
136.
See supra text accompanying note 80.
137.
See Draft Rules of Procedure, supra note 106, r. 40(b).
138.
See supra text accompanying notes 91–94.
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139

grant such motions to amend. It remains to be seen whether UPC amendment practice is permissive.
Compared to litigation-based PIPR in the United States, the UPC is
similar in the extent of available grounds (that is, any grounds that would
have prevented the patent’s issuance in the first place). But the UPC seemingly unifies the law of patent examination and review, whereas district
courts in the United States operate under different burden-of-proof and
140
claim-construction rules than the PTAB. The relaxed standing requirement is also significant in comparing the UPC to litigation in the United
States—a declaratory judgment action for patent invalidity in a US district
court has a heightened standing requirement, limited to situations where the
141
patent owner would otherwise have standing to sue the potential infringer.
In comparison, the UPC bolsters the ability of firms to reduce their own
economic uncertainty by bringing revocation actions before investment in
potentially infringing technologies.
Additionally, in US patent litigation, judges (and juries) are generalists;
the UPC, in contrast, employs judges with technical qualifications—with no
142
juries. Such expertise is likely to improve the quality and accuracy of
PIPR, at least compared to expert battles before US courts. In principle,
then, the UPC should be more likely to get technical questions right and to
143
accurately construe patent language. Further, unlike litigation, the UPC
revocation proceeding enables selective amendments of patents. Combined

139.
See Tietz, supra note 32, at 368.
140.
Anecdotally, patent examiners will often ignore citations to caselaw in patent applications and patent amendments unless the Patent Office has issued specific guidance documents.
141.
See 8 DONALD S. CHISUM, CHISUM ON PATENTS § 21.03[4] (discussing standing
for actions for declaratory judgment of patent invalidity). There is a generally lax standing
requirement for administrative PIPR in the United States, however. This makes the administrative route more viable as a means to combat patent trolls, enabling a broad “private patent
examiner” function. The actual use of IPR in the United States by parties without traditional
Article III standing highlights the potential use and abuse of this “private patent examiner”
function. See, e.g., Michelle Carniaux & Michael E. Sander, Activists and Investors: A New
Breed of IPR Petitioners?, IPR BLOG (June 20, 2014), http://interpartesreviewblog.com/
activists-investors-new-breed-ipr-petitioners/ (archived at https://web.archive.org/web/
20170118134439/http://interpartesreviewblog.com/activists-investors-new-breed-iprpetitioners/). For instance, the non-profit Electronic Frontier Foundation has taken to filing
petitioners for IPR to eliminate so-called “illegitimate patents” that it has no financial interest
in but sees as a threat to private citizens. Id. On the other hand, certain investors have filed
IPRs against companies they plan to short-sell, for the purpose of tanking stock prices. Id.; see
also Paul Barrett, How Patent Trolls Sparked a Failed Assault on High Drug Prices,
BLOOMBERG (Apr. 10, 2017, 2:10 PM), https://www.bloomberg.com/news/articles/2017-0410/how-patent-trolls-sparked-a-failed-assault-on-high-drug-prices.
142.
See supra text accompanying notes 72–83.
143.
See Lemley, Why Do Juries Decide?, supra note 47, at 1732 (“Specialization is
generally desirable; the European system arguably produces more accurate evaluations of a
patent’s validity than would a lay jury.”).
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with judicial expertise and equitable principles, this is likely to result in
144
more sensible decisions regarding patent validity and scope.
Compared to the United States, the UPC also benefits from a loser-pays
fee regime. In the United States, administrative PIPR is seen as viable in
145
part because it is substantially cheaper than litigation. But the lack of a
loser-pays fee system means that patent troll lawyers can operate on a lean,
contingent-fee basis, while those seeking PIPR necessarily incur costs. In
contrast, the UPCA establishes that the losing party at the UPC will general146
ly bear the costs of the winner. This reduces the financial burden on patent challengers, especially where the likelihood of success is high.
Thus, as an ex post anti-troll PIPR vehicle, UPC revocation actions
seem advantageous over PIPR in the United States in terms of availability,
judicial expertise, unification of standards, amendment practice, and forum
limitations. On the other hand, as discussed next, certain structural factors
limit the potential applicability of the UPC system to the patent troll problem.

B. The UPC May Inadvertently Disincentivize
Patent Owners from Participation
Despite its merits, PIPR under the UPC might be too-strong medicine.
As discussed in this Section, the UPC exists alongside national patent sys147
tems. Patent owners have a choice of where to file patents. Accordingly,
several features of the UPCA suggest that for patent owners in the industries
144.
See Mark A. Lemley, Scope, 57 WM. & MARY L. REV. 2197, 2224–25 (2016) (arguing that where the only option is declaring IP rights invalid altogether, rather than in part,
courts are reluctant to find invalidity).
145.
A motivation behind administrative PIPR in the United States was cost:
It was thought that having challengers file IPRs early in the district court litigation
process would allow the district court case to be stayed before substantial resources
were spent on the case and that patent validity issues would subsequently play out
in the lower-cost IPR process. If the patent validity was upheld in the IPR, the litigation would be streamlined because, as a result of the estoppel provisions, the
challenger would be estopped from contesting in district court any validity issue
that it could have presented in the IPR process; conversely, if the patent was invalidated in the IPR, the bulk of the district court litigation costs could be avoided entirely.
Daniel Golub, IPRs Complicate the Litigation Funding Landscape for Patent Owners,
LANDSLIDE (2015), https://www.americanbar.org/publications/landslide/2015-16/septemberoctober/iprs_complicate_litigation_funding_landscape_patent_owners.html.
146.
UPCA, supra note 51, art. 69(1) (“Reasonable and proportionate legal costs and
other expenses incurred by the successful party shall, as a general rule, be borne by the unsuccessful party, unless equity requires otherwise, up to a ceiling set in accordance with the Rules
of Procedure.”). The volume of recoverable costs at the UPC exceeds those available both in
the UK and in Germany. See Lunze & Rektorschek, supra note 119.
147.
See, e.g., About the UPC, supra note 52 (“The UPC will not have any competence
with regard to national patents.”).
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amenable to patent troll behavior, the risk to opting in may outweigh the
reward. Trolls may simply pick favorable national patent laws.
A crucial difference between the UPC and the United States is that in
148
Europe, the UPC does not preempt national patent law. In the United
States, a troll has only one patent system to opt into and must take with it
the PIPR mechanisms in place, however draconian they might seem. This is
not the case under the UPCA. For European patents, there will be a sevenyear transitional period in which a plaintiff may choose between the UPC
149
and national courts. For European patents filed before the end of this peri150
od, patent owners may opt out entirely from the UPC’s jurisdiction. And
inventors are free to pursue national patents instead.
There are several disadvantages, for patent owners, to the UPC system.
The first is the fee-shifting provision. As previously discussed, the loser will
151
generally pay, and so a patent owner risks being dragged into a revocation
action without even having intended to enforce its patent. In the case of
technology sectors with frequently overbroad patents—for instance, bio152
technology and computer technology —this risk is aggravated. The risk is
further aggravated by what looks like a lax standing requirement for bring-

148.
Patent law in the United States is federal, and patent infringement causes of action
are provided for by federal statute. See 35 U.S.C. § 271 (2012); 28 U.S.C. § 1498.
149.
See PATENT LITIGATION IN EUROPE, supra note 45, at 138.
150.
See id. at 137. Some law firms already recommend opting out. See, e.g., WilmerHale The Future European Patent System: Update on the Latest News, JDSUPRA (Spring
2016) https://www.jdsupra.com/legalnews/the-future-european-patent-system-74833/ (“The
possibility to opt out non-unitary European patents during the (initial) seven-year transitional
period is one which all patentees must consider, in order to shelter their patents from the risk
of a pan-European revocation by this unknown court.”).
151.
UPCA, supra note 51, art. 69(1) (“Reasonable and proportionate legal costs and
other expenses incurred by the successful party shall, as a general rule, be borne by the unsuccessful party, unless equity requires otherwise, up to a ceiling set in accordance with the Rules
of Procedure.”). Notably, the UPCA notes that the court may take equitable considerations
into account in fee-shifting, and the court’s draft rules on fees do institute a ceiling for fee
shifting, as well as accounting for fairness:
Article 69 of the Agreement qualifies the general rule that the unsuccessful party
shall bear the successful party’s costs by a number of principles, which serve as
important safeguards when the Court makes its decision on costs, by allowing for
exceptions from the general rule or limiting its application. . . . Firstly, only reasonable and proportionate legal costs and other expenses incurred by the successful
party may be recovered from the unsuccessful party. Moreover, equity may also
serve as a self-standing ground for rendering the general rule inapplicable. Furthermore, in case of partial success or in exceptional circumstances, the Court may
order the parties to bear their own costs, or apply a different apportionment of cost,
based on equity.
See RULES ON COURT FEES, supra note 128.
152.
See Natasha N. Aljalian, The Role of Patent Scope in Biopharmaceutical Patents,
11 B.U. J. SCI. & TECH. L. 1, 18 n.62 (2005) (discussing debate around whether biotechnological and software patents tend to be overbroad).
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153

ing a revocation action. Thus, where the value of an individual invention
154
is uncertain, a prospective patent owner might perceive a high risk to opting into the UPC.
The UPC’s autonomy also highlights an institutional-dynamics concern.
A product of an international treaty, the UPC is generally outside the control
and competence of national courts and legislatures with respect to patent
155
law issues. This lack of oversight was one reason that the legality of the
156
UPC was challenged, albeit unsuccessfully, before the Court of Justice.
Indeed, in what is perhaps surprising from the American perspective, the
validity of a national property right will essentially be decided by two intertwined and remarkably autonomous international bodies. Patent owners under the UPC’s jurisdiction might be concerned, for instance, about the fairness of its procedural rules or substantive decisions. Yet it is unclear how
patent owners could seek review. In contrast, the United States subjects the
157
PTAB to Article III judicial oversight. There is some apparent oversight
of the UPC, but it is limited. Decisions of the Court of Justice are binding,
158
for instance. But the Court of Justice has indicated that its oversight will
be limited—after all, patent eligibility is not governed by European Union
159
law. The Rules of Procedure are promulgated internally by the Adminis160
trative Committee. The UPCA does require that the European Commis161
sion be consulted, but, as with the Court of Justice, this oversight is limited to compatibility with European Union law. Further, the UPC is self-

153.
See supra text accompanying notes 98–125 (discussing standing). Although a
plaintiff incurs a fixed fee of €20,000 to bring a revocation action—a sort of procedural proxy
for the economic interest aspect of standing—this is still much lower than the average cost of
litigation. See RULES ON COURT FEES, supra note 128, at 9.
154.
See Sichelman, supra note 10, at 343 (“At [the filing] stage, especially for modern
technologies, an invention is usually not in the form of a finished product ready for sale, and
its commercial success is highly uncertain. . . . Indeed, many of the twentieth century’s greatest inventions, including the television, radio, radar, and penicillin, were not commercialized
until decades after they were invented.”).
155.
See Jens Schovsbo et al., The Unified Patent Court: Pros and Cons of Specialization—Is There a Light at the End of the Tunnel (Vision)?, 46 IIC 271, 273 (2015).
156.
See supra note 60.
157.
For instance, by means of the Administrative Procedure Act, see, e.g., 5 U.S.C.
§§ 701–706 (2012), as well as statutory appealability of various USPTO decisions, see, e.g.,
35 U.S.C. § 141 (2012).
158.
UPCA, supra note 51, art. 21.
159.
See Case C-146/13, Spain v. European Parliament, 2015 WL Celex No.
613CJ0146, ¶¶ 24, 28–32 (sidestepping Spain’s concerns that “the decisions of [the UPC]
boards of appeal are not subject to any form of judicial review, since the European Patent Organisation enjoys immunity from legal proceedings and enforcement”); id. ¶¶ 90, 101 (responding to concerns that the UPC “does not lay down any guarantees for the preservation of
EU law” by holding that “the Court does not have jurisdiction to rule on the lawfulness of an
international agreement concluded by Member States”).
160.
UPCA, supra note 51, art. 41.
161.
Id. art. 41(2).
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162

funding and thus not subject to external withholding or spending pressure.
The UPC, then, has more autonomy than the PTAB—a factor that might
make patent owners, who have little political representation to ensure fairness, hesitate.
Whether these factors matter will depend on the costs and benefits of
opting into the UPC. A prime consideration for a patent troll is the strength
of a market—the business model only works if there is a relatively wealthy
163
industry to pressure into settlements. And such a market might not be homogeneous across Europe. For instance, patent trolls tend to target companies in specific industries—namely, electronics, machinery, and computer
164
equipment —and these industries (and wealth) are not equally distribut165
ed. Basically, a patent owner might only desire patents in the one or two
countries with the potential for lucrative troll activity. Indeed, the incremental benefit of obtaining a unitary patent might be so low (for instance, no
other companies to seek licenses from) and the incremental risk might be so
high (for instance, twenty-five countries full of potential parties who could
bring individual revocation actions) that a unitary patent might not make
166
economic sense.
Nevertheless, one feature of the internal market—regional patent ex167
haustion —might limit the ability of patent trolls to rely only on select na168
tional patents. Like the concept of free movement of goods, the doctrine is
that patent rights are exhausted Union-wide for a product once it undergoes
169
an authorized sale anywhere in the European Union. Generally, exhaus162.
Id. art. 36(1).
163.
See Fusco, supra note 13, at 463–64 (“NPE activity is concentrated in markets
where potential target companies produce high revenues. NPEs do not operate in countries,
such as Poland, where the number of companies operating in the preferred industries is high,
but revenues are low.”).
164.
Id. at 456–57.
165.
See id. at 463–64.
166.
It might be argued that if there are no parties to assert patents against in a given
country, then there are probably no parties with sufficient economic interest to pay the
€20,000 revocation action fee. Nevertheless, certain countries might be active enough in the
given technology to want to strike down an invalid patent (perhaps via an action brought by a
collective interest group) but insufficiently wealthy to attract troll attention.
167.
See Philip P. Soo, Note, Enforcing a Unitary Patent in Europe: What the U.S. Federal Courts and Community Design Courts Teach Us, 35 LOY. L.A. INT’L & COMP. L. REV.
55, 67–68 (2012) (describing patent exhaustion in the EU); see also UPCA, supra note 51,
art. 29.
168.
TFEU, supra note 116, art. 26(2).
169.
See Case 15/74, Centrafarm BV v. Sterling Drug Inc., 1974 E.C.R. 1147
(“[O]bstacles to free movement may be justifiable for reasons of protection of industrial property when the protection is invoked against a product coming from a Member State in which it
is not patentable and has been manufactured by third parties without the consent of the patentee or where the original patentees are legally and economically independent of each other; the
derogation to the principle of free movement of goods is not justified when the product has
been lawfully put by the patentee himself or with his consent, on the market of the Member
State from which it is being imported, e.g. in the case of a holder of parallel patents.”).
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tion increases the incentive to seek as geographically broad patent protection as possible. Indeed, there is some suggestion that exhaustion limits pa170
tent troll activities.
Because patent trolls are typically exclusive licensees or assignees ra171
ther than inventors, this choice-of-law question might have a muted impact: if inventors opt for the UPC, then so must trolls. Thus, the economic
considerations for patent trolls are likely less relevant than the economic
considerations for inventors. Realistically, though, many inventors do not
commercialize technology but rely on patent pooling firms to purchase and
172
license their patents. Thus, the economic considerations of legitimate licensing firms and patent trolls are probably somewhat aligned. Of course,
these economic considerations might just incentivize increased scrutiny in
the drafting of patents expected to be economically important (and thus es173
pecially prone to validity challenges). That is, the prospect of heavy postissuance costs in defending or amending bad patents might incentivize in174
creased clarity and narrowly drafted patent claims. If so, this would indirectly accomplish the same goal as ex post PIPR of bad patents already in
the hands of trolls.
170.
See, e.g., Amelia Smith Rinehart, Contracting Patents: A Modern Patent Exhaustion Doctrine, 23 HARV. J.L. & TECH. 483, 530 (2010).
171.
See Sichelman, supra note 10, at 369 (characterizing patent trolls as “firms that do
not commercialize their patented inventions and perform little to no R & D”).
172.
Universities are one such example—although they frequently license patents, universities are not equipped to commercialize technology themselves. See Mark A. Lemley, Are
Universities Patent Trolls?, 18 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. 611, 613–20
(2008) (observing parallels between university technology transfer practice and patent troll
behavior).
173.
Predicting the value of a patent, however, is difficult, and most patents are worthless. See Sichelman, supra note 10, at 343 (“About half, probably more, of all patented inventions in the United States are never commercially exploited. . . . At [the prosecution] stage,
especially for modern technologies, an invention is usually not in the form of a finished product ready for sale, and its commercial success is highly uncertain”). Nonetheless, certain
broad technology areas are statistically more susceptible to challenge. See, e.g., USPTO,
PATENT TRIAL AND APPEAL BOARD STATISTICS 5 (Mar. 31, 2017),
https://www.uspto.gov/sites/default/files/documents/AIA%20Statistics_March2017.pdf (indicating that 60% of post-issuance patent challenges under the IPR mechanism in the US occur
within electrical and computer technologies).
174.
See Stephen Yelderman, Improving Patent Quality with Applicant Incentives, 28
HARV. J.L. & TECH. 77, 108–11 (2014) (arguing that the impact of an invalidity ruling “may
have the effect of pushing applicants toward narrower, more conservative claims”). But see
Tun-Jen Chiang, Fixing Patent Boundaries, 108 MICH. L. REV. 523, 526 (2010) (arguing that
the availability of amendments post-issuance is inefficient and that the best way to incentivize
good patent drafting ex ante is to disallow such amendments) (“[T]he ability to amend claims
allows patentees to cure any mistakes they make in drafting them. . . . Because patentees are
the least-cost avoider of claim-drafting mistakes, this shifting of loss is inefficient.”); Yelderman, supra at 111–12 (acknowledging that “procedural preferences for post-grant narrowing
amendments may create some incentives to seek broader claims in the first instance”). A feeshifting regime changes the cost calculus for a patent owner and arguably attenuates Professor
Chiang’s concern.
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Conclusion
Post-issuance patent review (PIPR) is an invaluable error-correcting
mechanism to prevent the socially harmful assertion of improperly issued
patents. With the America Invents Act, the United States has recently established a new system for PIPR, expanding administrative routes to curtail
bad patents. Europe has apparently gone a step further with the revocation
action created by the Unified Patent Court Agreement (UPCA). The UPCA
enables a revocation action on a broad range of grounds, at low cost, and
with a relaxed standing requirement. But this is also an opt-in system with a
loser-pays fee-shifting arrangement. Thus, although the structure of the
UPC appears to be set up to facilitate efficient PIPR, the disincentives for
opting in suggest that the UPC will be a less-effective troll-fighting vehicle
than expected.

